{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:28:40Z","timestamp":1787066920025,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160365"],"award-info":[{"award-number":["82160365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alveolar hypercoagulation and fibrinolytic inhibition are mainly responsible for massive alveolar fibrin deposition, which are closely related with refractory hypoxemia in acute respiratory distress syndrome (ARDS). Our previous study testified runt-related transcription factor (RUNX1) participated in the regulation of this pathophysiology in this syndrome, but the mechanism is unknown. We speculate that screening the downstream genes associated with RUNX1 will presumably help uncover the mechanism of RUNX1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Genes associated with RUNX1 were screened by CHIP-seq, among which the target gene was verified by Dual Luciferase experiment. Then the efficacy of the target gene on alveolar hypercoagulation and fibrinolytic inhibition in LPS-induced ARDS was explored in vivo as well as in vitro. Finally, whether the regulatory effects of RUNX1 on alveolar hypercoagulation and fibrinolytic in ARDS would be related with the screened target gene was also sufficiently explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among these screened genes, AKT3 was verified to be the direct target gene of RUNX1. Results showed that AKT3 was highly expressed either in lung tissues of LPS-induced rat ARDS or in LPS-treated alveolar epithelia cell type II (AECII). Tissue factor (TF) and plasminogen activator inhibitor 1 (PAI-1) were increasingly expressed both in lung tissues of ARDS and in LPS-induced AECII, which were all significantly attenuated by down-regulation of AKT3. Inhibition of AKT3 gene obviously ameliorated the LPS-induced lung injury as well as the collagen I expression in ARDS. RUNX1 overexpression not only promoted the expressions of TF, PAI-1, but also boosted AKT3 expression in vitro. More importantly, the efficacy of RUNX1 on TF, PAI-1 were all effectively reversed by down-regulation of AKT3 gene.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AKT3 is an important target gene of RUNX1, through which RUNX1 exerted its regulatory role on alveolar hypercoagulation and fibrinolytic inhibition in LPS-induced ARDS. RUNX1\/ATK3 signaling axis is expected to be a new target for the exploration of ARDS genesis and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-024-02689-2","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T09:25:02Z","timestamp":1706088302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["RUNX1 targeting AKT3 promotes alveolar hypercoagulation and fibrinolytic inhibition in LPS induced ARDS"],"prefix":"10.1186","volume":"25","author":[{"given":"Chuan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyangzi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"issue":"10300","key":"2689_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/s0140-6736(21)00439-6","volume":"398","author":"NJ Meyer","year":"2021","unstructured":"Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome. Lancet (London, England). 2021;398(10300):622\u201337. https:\/\/doi.org\/10.1016\/s0140-6736(21)00439-6.","journal-title":"Lancet (London, England)"},{"issue":"8","key":"2689_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788\u2013800. https:\/\/doi.org\/10.1001\/jama.2016.0291.","journal-title":"JAMA"},{"issue":"3","key":"2689_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jama.2016.6468","volume":"316","author":"K Zafar","year":"2016","unstructured":"Zafar K. Incidence of acute respiratory distress syndrome. JAMA. 2016;316(3):347. https:\/\/doi.org\/10.1001\/jama.2016.6468.","journal-title":"JAMA"},{"issue":"1","key":"2689_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13287-020-01804-6","volume":"11","author":"K Xiao","year":"2020","unstructured":"Xiao K, Hou F, Huang X, Li B, Qian ZR, Xie L. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19. Stem Cell Res Ther. 2020;11(1):305. https:\/\/doi.org\/10.1186\/s13287-020-01804-6.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"2689_CR5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3997","volume":"11","author":"S Ngu","year":"2019","unstructured":"Ngu S, Pervaiz S, Avula A, Chalhoub M. Rhinovirus-induced rapidly progressing acute respiratory distress syndrome in an immunocompetent host. Cureus. 2019;11(2): e3997. https:\/\/doi.org\/10.7759\/cureus.3997.","journal-title":"Cureus"},{"key":"2689_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/metabo10050207","author":"SM Metwaly","year":"2020","unstructured":"Metwaly SM, Winston BW. Systems biology ARDS research with a focus on metabolomics. Metabolites. 2020. https:\/\/doi.org\/10.3390\/metabo10050207.","journal-title":"Metabolites"},{"key":"2689_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.664209","volume":"12","author":"EJ Nossent","year":"2021","unstructured":"Nossent EJ, Schuurman AR, Reijnders TDY, Saris A, Jongerius I, Blok SG, de Vries H, Duitman J, Vonk Noordegraaf A, Meijboom LJ, Lutter R, Heunks L, Bogaard HJ, van der Poll T. Pulmonary procoagulant and innate immune responses in critically ill COVID-19 patients. Front Immunol. 2021;12: 664209. https:\/\/doi.org\/10.3389\/fimmu.2021.664209.","journal-title":"Front Immunol"},{"issue":"5","key":"2689_CR8","doi-asserted-by":"publisher","first-page":"L874","DOI":"10.1152\/ajplung.00372.2007","volume":"294","author":"JA Bastarache","year":"2008","unstructured":"Bastarache JA, Wang L, Wang Z, Albertine KH, Matthay MA, Ware LB. Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity. Am J Physiol Lung Cell Mol Physiol. 2008;294(5):L874\u201381. https:\/\/doi.org\/10.1152\/ajplung.00372.2007.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"2689_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1165\/rcmb.2014-0179OC","volume":"53","author":"CM Shaver","year":"2015","unstructured":"Shaver CM, Grove BS, Putz ND, Clune JK, Lawson WE, Carnahan RH, Mackman N, Ware LB, Bastarache JA. Regulation of alveolar procoagulant activity and permeability in direct acute lung injury by lung epithelial tissue factor. Am J Respir Cell Mol Biol. 2015;53(5):719\u201327. https:\/\/doi.org\/10.1165\/rcmb.2014-0179OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"2689_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/path.3992","volume":"228","author":"JJ Osterholzer","year":"2012","unstructured":"Osterholzer JJ, Christensen PJ, Lama V, Horowitz JC, Hattori N, Subbotina N, Cunningham A, Lin Y, Murdock BJ, Morey RE, Olszewski MA, Lawrence DA, Simon RH, Sisson TH. PAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury. J Pathol. 2012;228(2):170\u201380. https:\/\/doi.org\/10.1002\/path.3992.","journal-title":"J Pathol"},{"issue":"6","key":"2689_CR11","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1097\/TA.0b013e31820f85a7","volume":"70","author":"JJ Hofstra","year":"2011","unstructured":"Hofstra JJ, Vlaar AP, Knape P, Mackie DP, Determann RM, Choi G, van der Poll T, Levi M, Schultz MJ. Pulmonary activation of coagulation and inhibition of fibrinolysis after burn injuries and inhalation trauma. J Trauma. 2011;70(6):1389\u201397. https:\/\/doi.org\/10.1097\/TA.0b013e31820f85a7.","journal-title":"J Trauma"},{"key":"2689_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.omto.2018.12.008","volume":"12","author":"CC Sun","year":"2019","unstructured":"Sun CC, Li SJ, Chen ZL, Li G, Zhang Q, Li DJ. Expression and prognosis analyses of runt-related transcription factor family in human leukemia. Mol Therapy Oncolyt. 2019;12:103\u201311. https:\/\/doi.org\/10.1016\/j.omto.2018.12.008.","journal-title":"Mol Therapy Oncolyt"},{"issue":"24","key":"2689_CR13","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1038\/sj.onc.1207779","volume":"23","author":"M Osato","year":"2004","unstructured":"Osato M. Point mutations in the RUNX1\/AML1 gene: another actor in RUNX leukemia. Oncogene. 2004;23(24):4284\u201396. https:\/\/doi.org\/10.1038\/sj.onc.1207779.","journal-title":"Oncogene"},{"issue":"1","key":"2689_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12931-020-01372-6","volume":"21","author":"Y Wu","year":"2020","unstructured":"Wu Y, Wang Y, Liu B, Cheng Y, Qian H, Yang H, Li X, Yang G, Zheng X, Shen F. SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-kappaB p65 translocation. Respir Res. 2020;21(1):130. https:\/\/doi.org\/10.1186\/s12931-020-01372-6.","journal-title":"Respir Res"},{"key":"2689_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110318","volume":"120","author":"C Xiao","year":"2023","unstructured":"Xiao C, Li Q, Xiao J, Chen X, Yuan J, Li S, Li W, Gao D, Li L, Liu Y, Shen F. miR-9 targeting RUNX1 improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-\u03baB inactivation in ARDS. Int Immunopharmacol. 2023;120: 110318. https:\/\/doi.org\/10.1016\/j.intimp.2023.110318.","journal-title":"Int Immunopharmacol"},{"issue":"15","key":"2689_CR16","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1182\/blood-2010-12-323204","volume":"118","author":"KA O'Brien","year":"2011","unstructured":"O\u2019Brien KA, Stojanovic-Terpo A, Hay N, Du X. An important role for Akt3 in platelet activation and thrombosis. Blood. 2011;118(15):4215\u201323. https:\/\/doi.org\/10.1182\/blood-2010-12-323204.","journal-title":"Blood"},{"issue":"9","key":"2689_CR17","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/atvbaha.112.254680","volume":"32","author":"KA O'Brien","year":"2012","unstructured":"O\u2019Brien KA, Gartner TK, Hay N, Du X. ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3\u03b2. Arterioscler Thromb Vasc Biol. 2012;32(9):2232\u201340. https:\/\/doi.org\/10.1161\/atvbaha.112.254680.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2689_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/573210","volume":"2015","author":"S Yanagi","year":"2015","unstructured":"Yanagi S, Tsubouchi H, Miura A, Matsumoto N, Nakazato M. Breakdown of epithelial barrier integrity and overdrive activation of alveolar epithelial cells in the pathogenesis of acute respiratory distress syndrome and lung fibrosis. Biomed Res Int. 2015;2015: 573210. https:\/\/doi.org\/10.1155\/2015\/573210.","journal-title":"Biomed Res Int"},{"key":"2689_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10040756","author":"JP Margaria","year":"2022","unstructured":"Margaria JP, Moretta L, Alves-Filho JC, Hirsch E. PI3K signaling in mechanisms and treatments of pulmonary fibrosis following sepsis and acute lung injury. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10040756.","journal-title":"Biomedicines"},{"issue":"1","key":"2689_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s11658-022-00308-w","volume":"27","author":"MR Khezri","year":"2022","unstructured":"Khezri MR, Varzandeh R, Ghasemnejad-Berenji M. The probable role and therapeutic potential of the PI3K\/AKT signaling pathway in SARS-CoV-2 induced coagulopathy. Cell Mol Biol Lett. 2022;27(1):6. https:\/\/doi.org\/10.1186\/s11658-022-00308-w.","journal-title":"Cell Mol Biol Lett"},{"key":"2689_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1756-8722-5-16","volume":"5","author":"C Hu","year":"2012","unstructured":"Hu C, Huang L, Gest C, Xi X, Janin A, Soria C, Li H, Lu H. Opposite regulation by PI3K\/Akt and MAPK\/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells. J Hematol Oncol. 2012;5:16. https:\/\/doi.org\/10.1186\/1756-8722-5-16.","journal-title":"J Hematol Oncol"},{"issue":"15","key":"2689_CR22","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1161\/01.cir.0000015465.73933.3b","volume":"105","author":"M Eto","year":"2002","unstructured":"Eto M, Kozai T, Cosentino F, Joch H, L\u00fcscher TF. Statin prevents tissue factor expression in human endothelial cells: role of Rho\/Rho-kinase and Akt pathways. Circulation. 2002;105(15):1756\u20139. https:\/\/doi.org\/10.1161\/01.cir.0000015465.73933.3b.","journal-title":"Circulation"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02689-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-024-02689-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02689-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T09:29:04Z","timestamp":1706088544000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-024-02689-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2689"],"URL":"https:\/\/doi.org\/10.1186\/s12931-024-02689-2","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"assertion":[{"value":"6 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal ethics approval has been granted by Guizhou Medical University Hospital. Participants consent to publish is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}